From February 3rd to 6th, 2025, MEDLAB, the largest medical laboratory exhibition in the Middle East, was successfully held in Dubai. Orient Gene made a remarkable appearance at the event, showcasing a range of innovative products that captured the attention of industry experts, clients, and partners.

As a globally leading medical device company, Orient Gene presented its high-quality product lines, including Immunoassay, Dry biochemistry, Quantum-Beads Flowcytometry, and Molecular diagnosis. Among the highlights was the Fluorescent Immunoassay Analyzer, which became a focal point at the exhibition. Our multi-model Fluorescent Immunoassay Analyzers, several of which have obtained CE certification, are capable of detecting more than 50 parameters, meeting diverse clinical diagnostic needs.

Equally impressive was the POCT PCR instrument, which stands out with its four core advantages: easy to operate, fully automated, all-in-one close cartridge, and extensive test menu. This instrument delivers efficient and reliable testing experiences, aiming to deliver speed, accuracy to patients, and convenience to doctors at the point of care.

MEDLAB serves as a vital platform for the medical industry in the Middle East, offering Orient Gene an opportunity to demonstrate its innovative capabilities and expand its global market presence. During the exhibition, the Orient Gene team engaged in in-depth discussions with clients and partners worldwide, exploring potential collaborations and sharing the company's latest technological achievements in molecular diagnosis and immunoassay.

Orient Gene remains committed to delivering high-quality medical diagnostic solutions to global clients. Through this exhibition, the company not only enhanced its brand influence but also injected new vitality into the healthcare industry in the Middle East and North Africa region. Moving forward, Orient Gene will continue to drive innovation and contribute to the advancement of global healthcare.